Overview To Evaluate the Efficacy and Safety of DW-1401 in Acute and Chronic Gastritis Patients Status: Completed Trial end date: 2014-11-01 Target enrollment: Participant gender: Summary Evaluate the Efficacy and Safety of DW1401 versus Stillen tab. in Patients with Acute or Chronic Gastritis Phase: Phase 3 Details Lead Sponsor: Daewon Pharmaceutical Co., Ltd.